Traumatic optic neuropathy therapy: An update of clinical and experimental studies

Journal of International Medical Research

Volumn 36, Issue 5, 2008, Pages 883-889

  Wu, N ^a   Yin, Zheng Qin ^a   Wang, Yi ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Optic nerve; Retinal Ganglion cells; Traumatic optic neuropathy

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTEROID; CRYSTALLIN; DIZOCILPINE; ERYTHROPOIETIN; GLUTAMATE RECEPTOR ANTAGONIST; LOMERIZINE; MEMANTINE; METHYLPREDNISOLONE; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYTOIN; PLACEBO; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; GLUTAMIC ACID; NERVE GROWTH FACTOR; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

BLINDNESS; CLINICAL RESEARCH; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EXPERIMENTAL STUDY; HUMAN; IMMUNE SYSTEM; NERVE DECOMPRESSION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; REVIEW; TRAUMATIC OPTIC NEUROPATHY; VISUAL IMPAIRMENT; ANIMAL; DECOMPRESSION SURGERY; DRUG EFFECT; METABOLISM; OPTIC NERVE; OPTIC NERVE INJURY; PATHOLOGY; PHYSIOLOGY; RETINA GANGLION CELL;

ANIMALS; BLINDNESS; CLINICAL TRIALS AS TOPIC; CRYSTALLINS; DECOMPRESSION, SURGICAL; GLUTAMIC ACID; HUMANS; NERVE GROWTH FACTORS; NITRIC OXIDE; OPTIC NERVE; OPTIC NERVE DISEASES; OPTIC NERVE INJURIES; RETINAL GANGLION CELLS; STEROIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 54449090234     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600503     Document Type: Review

References (48)

1. Steinsapir KD, Goldberg RA: Traumatic optic neuropathy. Surv Ophthalmol 1994; 38: 487-518.
2. Sarkies N: Traumatic optic neuropathy. Eye 2004; 18: 1122-1125.
3. Matsuzaki H, Kunita M, Kawai K: Optic nerve damage in head trauma: clinical and experimental studies. Jpn J Ophthalmol 1982; 26: 447-461.
4. Fugitani T, Inoue K, Takahashi T, et al: Indirect traumatic optic neuropathy-visual outcome of operative and nonoperative cases. Jpn J Ophthalmol 1986; 30: 125-134.
5. Seiff SR: High dose corticosteroids for treatment of vision loss due to indirect injury to the optic nerve. Opthalmic Surg 1990; 21: 389-395.
6. Joseph MP, Lessell S, Rizzo J, et al: Extracranial optic nerve decompression for traumatic optic neuropathy. Arch Ophthalmol 1990; 108: 1091-1093.
7. Mahapatra AK, Tandon DA: Traumatic optic neuropathy in children: a prospective study. Pediatr Neurosurg 1993; 19: 34-39.
8. Chou PI, Sadun AA, Chen YC, et al: Clinical experiences in the management of traumatic optic neuropathy. Neuro-ophthalmology 1996; 16: 325-336.
9. Chen HY, Tsai RK, Wang HZ: Intravenous methylprednisolone in treatment of traumatic optic neuropathy. Kaohsiung J Med Sci 1998; 14: 577-583.
10. Gu N, Yin S, Shen P: Trans-ethmoidal optic nerve decompression in traumatic optic neuropathy. Lin Chuang Er Ri Yan Hou Ke Za Zhi 1998; 12: 451-453.
11. Li KK, Teknos TN, Lai A, et al: Traumatic optic neuropathy: result in 45 consecutive surgically treated patients. Otolaryngal Head Neck Surg 1999; 120: 5-11.
12. Mine S, Yamakami I, Adachi-Usami E: Outcome of traumatic optic neuropathy. Comparison between surgical and nonsurgical treatment. Acta Neurochir (Wien) 1999; 141: 27-30.
13. Levin LA, Beck RW, Joseph MP, et al: The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology 1999; 106: 1268-1277.
14. Wang BH, Robertson BC, Girotto JA, et al: Traumatic optic neuropathy: a review of 61 patients. Plast Reconstr Surg 2001; 107: 1655-1664.
15. Wohlrab TM, Maas S, de Carpentier JP: Surgical decompression in traumatic optic neuropathy. Acta Ophthalmol Scand 2002; 80: 287-293.
16. Chuenkongkaew W, Chirapapaisan N: A prospective randomized trial of megadose MP and high dose dexamethasone for traumatic optic neuropathy. J Med Assoc Thai 2002; 85: 597-603.
17. Yip CC, Chng NW, Au Eong KG, et al: Low-dose intravenous MP or conservative treatment in the management of traumatic optic neuropathy. Eur J ophthalmol 2002; 12: 309-314.
18. Rajiniganth MG, Gupta AK, Gupta A, et al: Traumatic optic neuropathy: visual outcome following combined therapy protocol. Arch Otolaryngol Head Neck Surg 2003; 129: 1203-1206.
19. Chen CT, Huang F, Tsay PK, et al: Endoscopically assisted transconjunctival decompression of traumatic optic neuropathy. J Craniofac Surg 2007; 18: 19-26.
20. Entezari M, Rajavi Z, Sedighi N, et al: High-dose intravenous MP in recent traumatic optic neuropathy; a randomized double-masked placeba-controlled clinical trial. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1267-1271.
21. Wolin MJ, Lavin PJM: Spontaneous visual recovery from traumatic optic neuropathy after blunt head injury. Am J Ophthalmol 1990; 109: 430-435.
22. Braken MB, Shepard MJ, Collins WF, et al: A randomized controlled trial of MP or naloxone in the treatment of acute spinal cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322: 1405-1411.
23. Bruken MB, Shepard MJ, Hoford TR, et al: Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow-up. Results of the Third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998; 89: 699-706.
24. Sheng Y, Zhu Y, Wu L: Effect of high dosage of methylprednisolone on rat retinal ganglion cell apoptosis after optic nerve crush. Yan Ke Xue Bao 2004; 20: 181-186.
25. Ohlsson M, Westerlund U, Langmoen IA, et al: Methylprednisolone treatment does not influence axonal regeneration or degeneration following optic nerve injury in the adult rat. J Neuro-ophthalmol 2004; 24: 11-18.
26. Yu-Wai-Man P, Griffiths PG: Steroids for traumatic optic neuropathy. Cochrane Database Syst Rev 2007; 17: CD006032.
27. Edwards P, Arango M, Balica L, et al: Final results of MRC CRASH, a trial of intravenous corticosteroid in adults with head injury outcomes at 6 months. Lancet 2005; 365: 1957-1959.
28. Ohlsson M, Svensson M: Early decompression of the injured optic nerve reduces axonal degeneration and improves functional outcome in the adult rat. Exp Brain Res 2007; 179: 121-130.
29. Steinsapir KD, Goldberg RA: Traumatic optic neuropathy: a critical update. Comp Ophthalmol Update 2005; 6: 11-12.
30. Onofrey CB, Tse DT, Johnson TE, et al: Optic canal decompression: a cadaveric study of the effects of surgery. Ophthal Plast Reconstr Surg 2007; 23: 261-266.
31. Dkhissi O, Chanut E, Wasowicz M, et al: Retinal TUNEL positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest Ophthalmol Vis Sci 1999; 40: 990-998.
32. WoldeMussie E, Yoles E, Schwartz M, et al: Neuroprotective effect of memantine in different retinal injury models in rats. J Glaucoma 2002; 11: 474-480.
33. Schuettauf F, Naskar R, Vorwerk CK, et al: Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors. Invest Ophthalmol Vis Sci 2000; 41: 4313-4316.
34. Sapieha PS, Peltier M, Rendahl KG, et al: FGF-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury. Mol Cell Neurosci 2003; 24: 656-672.
35. Chen H, Weber AJ: BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest Ophthalmol Vis Sci 2001; 42: 966-974.
36. ALS-CNTF-Treatment Study Group (ACTSG): A double-blind placebo-controlled clinical trial of subcutaneous rhCNTF in amyotrophic lateral sclerosis. Neurology 1996; 46: 1244-1249.
37. Zhang L, Zhang C, Wang Y: Protection of α-crystalline via intravitreal injection on retinal ganglion cells after optic nerve injury. Chin J Trauma 2007; 23: 368-372 [in Chinese].
38. Wang Y, Yi Wang: Effect of α-crystallines on survival and growth of rat retinal ganglion cells in vitro. Chin J Trauma 2005; 21: 98-103 [in Chinese].
39. Fischer D, Hauk TG, Müller A, et al: Crystallins of the β/γ-superfamily mimic the effects of lens injury and promote axon regeneration. Mol Cell Neurosci 2008; 37: 471-479.
40. Lam TT, Tso MOM: Nitric oxide synthase (NOS) inhibitors ameliorate retinal damage induced by ischemia in rats. Res Commun Mol Pathol Pharmacol 1996; 92: 329-340.
41. Tezel G, Yang X, Yang J: Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice. Brain Res 2004 23; 996: 202-212.
42. Fisher J, Levkovitch-Verbin H, Schori H, et al: Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J Neurosci 2001; 21: 136-142.
43. Laquis S, Chaudhary P, Sharma SC: The patterns of retinal ganglion cell death in hypertensive eyes. Brain Res Bull 1998; 84: 100-104.
44. Okada T, Ichikawa M, Tokita Y, et al: Intravitreal macrophage activation enables cat RGCs to regenerate injured axons into the mature optic nerve. Exp Neurol 2005; 196: 153-163.
45. Dreyer EB: A proposed role for excitotoxicity in glaucoma. J Glaucoma 1998; 7: 62-67.
46. Karim Z, Sawada A, Kawakami H, et al: A new calcium channel antagonist, lomerizine, alleviates secondary RGCs death after optic nerve injury in the rat. Curr Eye Res 2006; 31: 273-283.
47. King CE, Rodger J, Bartlett C, et al: Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp Neurol 2007; 205: 48-55.
48. Levkovitch-Verbin H, Kalev-Landoy M, Habot-Wilner Z: Minocycline delays death of RGs in experimental glaucoma and after optic nerve transection. Arch Ophthalmol 2006; 124: 520-526.